GovChime
Notice ID: 32c9caafecdb4867ba182d135fcfdaccCombined Synopsis/SolicitationArchived

Bruker Biospin Nuclear Magnetic Resonance (NMR) and Q-Band Electron Paramagnetic Resonance Equipment

Archived on August 14, 2026. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
9:00 AM EDT
Posted
August 4, 2026
Notice type
Combined Synopsis/Solicitation
Set-aside
No Set aside used
NAICS
334516: Analytical Laboratory Instrument Manufacturing
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NICHD
Place of performance
Bethesda, 20892
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
75N98026Q00920
Notice ID
32c9caafecdb4867ba182d135fcfdacc

Description

1. GENERAL INFORMATION This is a combined synopsis/solicitation for commercial products prepared in accordance with FAR Part 12, as supplemented with additional information included in this notice, and in conjunction with FAR Subpart 12.6. This announcement constitutes the only solicitation; quotations are being requested, and a separate written solicitation will not be issued. The National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) , Intends to acquire new Bruker Biospin Nuclear Magnetic Resonance (NMR) and Q-Band Electron Paramagnetic Resonance Equipment Upgrades to Expand Research Capabilities and Replace End-of-Life Instrumentation or Equal. SEE ATTACHMENT for Bruker Biospin NMR Product List This acquisition is being conducted as an open market purchase. The Government intends to award a Firm-Fixed-Price Purchase Order resulting from this solicitation. 2. Description of Requirement 2.1 Background The National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Laboratory of Chemical Physics (LCP), conducts advanced research in biomolecular structure, conformational dynamics, and molecular mechanisms using nuclear magnetic resonance (NMR) spectroscopy and electron paramagnetic resonance (EPR) spectroscopy. The advanced NMR and EPR instrumentation in the LCP support mission-critical biomedical research. The federally conducted research programs focus on: Structural and dynamic characterization of proteins and nucleic acid Mechanisms of phosphorylation and regulation in intrinsically disordered proteins Transient conformational states associated with ligand and substrate binding Sparsely populated excited states of proteins associated with macromolecular recognition, allostery, assembly and fibril formation Long-range distance measurements in biomolecules using pulsed Q-band EPR techniques This research supports NIH’s mission to advance fundamental knowledge of biological systems and to improve understanding of disease mechanisms relevant to diabetes, metabolic disorders and related conditions, and neurodegenerative conditions associated with protein fibril formation and aggregation leading to a variety of amyloidosis. High-field 600-MHz NMR spectrometers equipped with cryogenic probe technology and Q-band pulsed EPR spectrometers capable of Double Electron-Electron Resonance (DEER) measurements are essential infrastructure for this research. These complementary methods provide distance measurements and structural and dynamic information that is not obtainable by other biophysical techniques. NMR provides atomic resolution information that allows almost every atom in a protein to be probed. While one of the main sources of structural information provided by NMR relates to interproton distances separated by less than 5-10 Å, pulsed Q-band EPR spectroscopy, particularly Double Electron–Electron Resonance (DEER) enables distance measurements between pairs of paramagnetic centers ranging from 20-160 Å. When combined with rapid mixing/freeze-quenching methods, DEER measurements can provide critical insight into kinetics and mechanisms of conformational transitions. 2.2 Objective To obtain NMR and Q-Band Electron Paramagnetic Resonance Equipment Upgrades to Expand Research Capabilities and Replace End-of-Life Instrumentation 3. Product Specifications/Features/Salient Characteristics Required Minimum Specifications See Attachment. 3.1 Services Requirements The vendor shall provide: 1. Delivery to NIH Main campus in Bethesda, MD. 2. Installation and operational startup. 3. Manufacturer warranty coverage; and 4. Manufacturer-supported service associated with the delivered system. 4. Delivery, installation, startup shall be performed at: National Institutes of Health Bldg. 5, Room B1-3001 Bethesda, MD 20892 5. Basic For Award The Government intends to award to the quoter whose quotation represents the best value to the Government, considering the following evaluation factors: 1. Technical Acceptability 2. Past Performance 3. Price 5.1 Technical Acceptability Technical acceptability is the most important factor. The Government will evaluate whether the quoted product meets all salient characteristics and minimum requirements of this solicitation. For any “equal” product, the vendor must provide sufficient technical documentation to demonstrate equivalency, including product literature, specifications, brochures, and point-by-point crosswalk to each salient characteristic. Failure to clearly demonstrate compliance with all minimum requirements may render the quotation unacceptable. 5.2 Past Performance The Government will evaluate the vendor’s record of recent and relevant past performance. The Government may consider information obtained from the vendor, CPARS, prior Government experience, and other available sources. 5.3 Pice Price will be evaluated for fairness and reasonableness. The Government may make an award to other than the lowest-priced quotation if a higher-rated quotation is determined to provide the best value. 6. Quotation Instructions Vendors shall submit a complete quotation package that includes the following: 6.1 Volume I – Technical Quote The technical quote shall include: Manufacturer name and model number. Description of the quoted system. Point-by-point response to each salient characteristic. Description of included software, accessories, automation, warranty, applicable service. Delivery lead time; Installation. 6.2 Volume II – Past Performance Provide up to three examples of recent and relevant contracts or purchase orders for customer name, dollar value, period of performance, point of contact with email and phone number. 6.3 Volume III – Price Quote The price quote shall include: unit price, extended price, total quoted price, any shipping charges, warranty information, any other separately priced items. The total quoted price shall include all costs necessary to provide a complete and fully functional system meeting the requirements of this solicitation. 6.4 SAM Registration In order to receive an award, offerors/contractors must maintain an active SAM registration for all awards throughout the entire contract/order lifecycle, from offer submission to final payment. Failure to maintain an active SAM registration can the award or result in non-payment. Lack of valid registration in SAM will make an offerors/contractor ineligible for award. 6.5 Small Business Subcontracting Plan In accordance with FAR 52.219-9, other-than-small-business (large business) offerors must submit a Small Business Subcontracting Plan with their quote. This requirement does not apply to small business concerns. If the offeror represents itself as a small business under the designated NAICS code for this procurement, no subcontracting plan is required." Other-than-small-business offerors who determine that zero subcontracting opportunities exist for this microscope procurement are still required to submit a formal Small Business Subcontracting Plan. The plan must state 0% goals and include a detailed, written justification outlining why subcontracting is not feasible (e.g., fully integrated in-house manufacturing). Failure to submit a plan with the required justification will render the quote non-responsive." 7. Submission Instructions Quotations shall be submitted electronically to: Tina Robinson@ robinsti@mail.nih.gov Quotations are due no later than: August 13, 2026, prior to 9:00 AM Eastern Daylight Time Late submissions may be rejected and not considered for award. 8. Clauses and Provisions The following FAR provisions and clauses apply to this acquisition, in addition to any others required by law or agency policy: 52.212-1 Instructions to Offerors—Commercial Products and Commercial Services 52.240-90 Security Prohibitions and Exclusions—Representations and Certifications 52.203-17 Contractor Employee Whistleblower Rights 52.203-19 Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements 52.204-13 System for Award Management — Maintenance 52.209-6 Protecting the Government’s Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment 52.209-10 Prohibition on Contracting with Inverted Domestic Corporations 52.212-4 Terms and Conditions—Commercial Products and Commercial Services 52.219-8 Utilization of Small Business Concerns 52.219-9 Small Business Subcontracting Plan 52.219-16 Liquidated Damages—Subcontracting Plan 52.222-3 Convict Labor 52.222-19 Child Labor—Cooperation with Authorities and Remedies 52.222-35 Equal Opportunity for Veteran 52.222-36 Equal Opportunity for Workers with Disabilities 52.222-37 Employment Reports on Veterans 52.222-40 Notification of Employee Rights Under the National Labor Relations Act 52.222-50 Combating Trafficking in Persons 52.222-54 Employment Eligibility Verification 52.223-23 Sustainable Products and Services 52.225-5 Trade Agreements 52.225-6 Trade Agreements Certificate 52.226-8 Encouraging Contractor Policies to Ban Text Messaging While Driving 52.232-33 Payment by Electronic Funds Transfer—System for Award Management 52.232-40 Providing Accelerated Payments to Small Business Subcontractors 52.233-3 Protest After Award 52.233-4 Applicable Law for Breach of Contract Claim 52.240-91 Security Prohibitions and Exclusions 52.244-6 Subcontracts for Commercial Products and Commercial Services 9. Brand Name of Equal Information This requirement is issued on a brand name or equal basis. The referenced brand name product is the Bruker Biospin Corporation products provided on the attachment. Any quotation offering an “equal” product must include sufficient descriptive material to permit the Government to determine whether the product offered meets all salient characteristics identified in the solicitation. The burden is on the vendor to establish equivalency. The Government is not responsible for locating or obtaining any information not identified in the quotation. If the vendor is providing an equal product(s), please supply descriptive data for evaluation purposed to determine the validity of how it is equal. The following FAR provision applies to this solicitation FAR 52.211.6 Brand Name or Equal. (a) if an item in this solicitation is identified as "brand name or equal," the purchase description reflects the characteristics and level of quality that will satisfy the Government’s needs. The salient physical, functional, or performance characteristics that "equal" products must meet are specified in the solicitation/attachment. (b) To be considered for award, offers of “equal” product, including “equal” products of the brand name manufacturer, must - (1) Meet the salient physical, functional or performance characteristics specified in this solicitation. (2) Clearly identify the item by - (i) Brand name, if any: and (ii) Make or model number (3) Include descriptive literature such as illustrations, drawings, or a clear reference to previously furnished descriptive data or information available to the Contracting Officer/Specialist; and (4) Clearly describe any modifications the offeror plans to make in a product to make it conform to the solicitation requirements. Mark any descriptive material to clearly show the modifications. (c) The Contracting Officer/Specialist is not responsible for locating or obtaining any information not identified in the offer. (d) Unless the offer clearly indicates in its offer that the product being offered is an "equal" product, the offer shall provide the brand name product referenced in the solicitation/attachment. 10. Important Notice This solicitation is issued as a competitive RFQ. The Government reserves the right to: make award without discussions. request clarification if needed reject any or all quotations; and Quoters are advised that the Government may share your information with non-government personnel who are assisting with the evaluation of quotes. The exclusive responsibility for source selection will reside with the Government. By submitting yoru quote, you will be consenting to disclosure of your quote to non-government personnel for purposes of evaluation.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

ROBINSON, TINA

Documents

Files (2)

  • Product Specifications Features Salient Characteristics.pdf

    138 KBAdded in Combined Synopsis/Solicitation version 3Posted
    Download
  • Bruker Biospin NMR Product List.pdf

    186 KBAdded in Combined Synopsis/Solicitation version 3Posted
    Download

Lifecycle

  1. 3
    Version 3Combined Synopsis/SolicitationArchivedCurrent

    Bruker Biospin Nuclear Magnetic Resonance (NMR) and Q-Band Electron Paramagnetic Resonance Equipment

    Notice 32c9caafecdb4867ba182d135fcfdacc on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98027Q00038 /PCA-NIA-11810. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition. This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold.
-Combined Synopsis12/08/2026
NON-COMPETITIVE COMBINED SYNOPSIS / SOLICITATION Title: Hidex 600SLe Liquid Scintillation Counter (i) This is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii) The solicitation number is 75N98027Q00033 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial product or commercial service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Products and Commercial Services and is not expected to exceed the simplified acquisition threshold. THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL AND OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH), Office of Acquisition and Logistics Management (OALM), on behalf of the NIH Office of Research Services (ORS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) for the purchase of a Hidex 600SLe Liquid Scintillation Counter. The anticipated award date is 10/30/2026. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2026-01, with effective date 03/13/2026. (iv) The associated NAICS code is 334516 and the small business size standard is 1000 employees. (v) The Contractor shall provide the following Hidex brand equipment: 600 SLe LSC with MikroWin. Catalog Number: AH-20XX-09. Quantity: 1. Alpha/Beta Separation for 300/600SL. Catalog Number: AH-NXX-04. Quantity: 1. Eu-152 External Standard. Catalog Number: AH-NXX-13. Quantity: 1. Windows 11 Desktop PC with Monitor. Catalog Number: P3G-36XX-01. Quantity: 1. Installation and Training. Catalog Number: GL-Z1XX-24. Quantity: 1. Shipping Contractor must also provide pricing for a trade-in discount. NIH will be trading in two old pieces of equipment in this acquisition. (vi) The Government anticipates award of a firm fixed-price purchase order for this acquisition, and the anticipated delivery date is 6-8 weeks ARO. (vii) The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html https://www.acquisition.gov/caac-letters (End of provision) The following provisions apply to this acquisition and are incorporated by reference: FAR 52.204-7, System for Award Management (Nov 2024) FAR 52.204-16, Commercial and Government Entity Code Reporting (Aug 2020) FAR 52.204-29, Federal Acquisition Supply Chain Security Act Orders – Representation and Disclosures (Dec 2023) FAR 52.212-1, Instructions to Offerors-Commercial Products and Commercial Services (Sep 2023) FAR 52.212-3, Offeror Representations and Certifications-Commercial Products and Commercial Services (May 2024) (DEVIATION Feb 2025) CAAC_Letter_2025-01_Supplement-1.pdf and CAAC_Letter_2025-02_Supplement-1.pdf FAR 52.222-52, Exemption from Application of the Service Contract Labor Standards to Contracts for Certain Services-Certification (May 2014) The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998), applies to this acquisition. This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html https://www.acquisition.gov/caac-letters (End of clause) The following clauses apply to this acquisition and are incorporated by reference: FAR 52.204-13, System for Award Management Maintenance (Oct 2018) FAR 52.204-18, Commercial and Government Entity Code Maintenance (Aug 2020) FAR 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services (Nov 2023). The following provisions and clauses apply to this acquisition and are attached in full text. Offerors MUST complete the provisions below and submit completed copies as separate documents with their proposal. FAR 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Nov 2021) FAR 52.204-26 Covered Telecommunications Equipment or Services-Representation (Oct 2020) FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Products and Commercial Services ( Jan 2025) (DEVIATION Feb 2025) Per CAAC Letters 2025-01 and 2025-02, FAR 52.222-21, Prohibition of Segregated Facilities and FAR 52.222-26 - Equal Opportunity will not be considered when making award decisions or enforce requirements. FAR 52.222-52 Exemption from Application of the Service Contract Labor Standards to Contracts for Certain Services-Certification (May 2014). HHSAR 352.239-78, Information and Communication Technology Accessibility Notice (Feb 2024) (DEVIATION). HHSAR 352.239-79, Information and Communication Technology Accessibility (Feb 2024) (DEVIATION). FAR DEVIATION STATEMENT: The CAAC Letter 2025-01 -Supplement 1 and CAAC Letter 2025-02-Supplement 1 are applicable to this acquisition. System updates may lag policy updates. The System for Award Management (SAM) may continue to require entities to complete representations based on provisions that are not included in agency solicitations. Examples include 52.222-25, Affirmative Action Compliance, and paragraph (d) of 52.212-3, Offeror Representations and Certifications—Commercial Products and Commercial Services. Contracting officers will not consider these representations when making award decisions or enforce requirements. Entities are not required to, nor are they able to, update their entity registration to remove these representations in SAM. The mentioned CAAC Letters may be accessed electronically at this address: CAAC Letters | Acquisition.GOV. The following invoice instruction is included and will be incorporated in the final award: NIH Invoicing Instructions with IPP (Mar 2023). (viii) The provision at FAR clause 52.212-2, Evaluation – Commercial Products and Commercial Services (Nov 2021), applies to this acquisition. (a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation is the lowest-priced technically-acceptable. (c) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer’s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award. (ix) Offerors must include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Products and Commercial Services (May 2024) (DEVIATION Feb 2025), with its offer. If the offeror has completed FAR clause 52.212-3 at www.sam.gov, then the offeror does not need to provide a completed copy with its offer. See DEVIATION STATEMENT above regarding applicable CAAC Letters. (x) The following additional contract requirement(s) or terms and conditions as determined by the contracting officer are necessary for this acquisition and consistent with customary commercial practices. There are no additional contract requirement(s) or terms and conditions applicable to this acquisition. (xi) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. (xii) Responses to this solicitation must include sufficient information to establish the interested parties’ bona-fide capabilities of providing the product or service. The price quote shall include: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s), product description, and any other information or factors that may be considered in the award decision. Such factors may include: past performance, special features required for effective program performance, trade-in considerations, probable life of the product selected as compared with that of a comparable product, warranty considerations, maintenance availability, and environmental and energy efficiency considerations. Responses to this solicitation must include clear and convincing evidence of the offeror’s capability of fulfilling the requirement as it relates to the technical evaluation criteria. The price proposal must include the labor categories, an estimate of the number of hours required for each labor category, fully loaded fixed hourly rate or each labor category, breakdown and rationale for other direct costs or materials, and the total amount. The Unique Entity ID from SAM.gov, the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. All quotations must be received by 12:00p.m., Eastern Standard Time, on October 29, 2026, and reference Solicitation Number 75N98027Q00033. Responses must be submitted electronically to Kevin Alvarez, Contracting Officer, kevin.alvarez@nih.gov. A determination by the Government whether to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered to determine whether to proceed on a non-competitive basis as indicated above, or to conduct a competitive procurement. Fax responses will not be accepted.
-Special Notice10/29/2026
(i)This is a combined synopsis/solicitation for commercial items prepared in accordancewith FAR Subpart 12.6, as supplemented with additional information included in thisnotice. This announcement constitutes the only solicitation; proposals are beingrequested, and a separate written solicitation will not be issued. (ii)The solicitation number is 75N98027Q00077. This solicitation is issued as a competitiveRequest for Quotation (RFQ) / combined synopsis/solicitation for commercial productsand commercial services using a Brand Name restriction in accordance with FAR 13.106-1(b)(1)(i). A Brand Name Justification is attached to this notice in accordance with FAR5.102(a)(6). This acquisition is conducted under the authority of FAR 12.603, StreamlinedSolicitation for Commercial Products or Commercial Services, in conjunction with FAR Part13 Simplified Acquisition Procedures, and is not expected to exceed the simplifiedacquisition threshold. The National Institutes of Health (NIH), Office of the Director, Officeof Acquisitions, seeks to award a Firm-Fixed-Price (FFP) Purchase Order to theresponsible offeror whose quotation represents the best value to the Government. (iii)The solicitation document and incorporated provisions and clauses are those in effectthrough Federal Acquisition Circular (FAC) number 2026-01 and effective date 03/13/2026. (iv)The associated NAICS code is 334516 (Analytical Laboratory InstrumentManufacturing), and the small business size standard is 1,000 employees. The ProductService Code (PSC) is 6640 (Laboratory Equipment and Supplies). [X]This requirement is set aside for Small Business concerns.
-Combined Synopsis11/24/2026
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98027Q00072. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services restricted to the Brand Name specified herein in accordance with FAR 13.106-1(b)(1)(i). The Government intends to award a firm-fixed-price purchase order resulting from this solicitation using competition among the Original Equipment Manufacturer (OEM) and its authorized distributors. This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, on behalf of the National Heart, Lung, and Blood Institute (NHLBI), seeks to award a firm-fixed-price purchase order to the responsible offeror whose proposal represents the best value to the Government. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026. (iv) The associated NAICS code is 334516 (Analytical Laboratory Instrument Manufacturing), and the small business size standard is 1,000 employees. ¿ This requirement is unrestricted. (v) Description of Requirement: The National Heart, Lung, and Blood Institute (NHLBI), Laboratory of Advanced Microscopy and Biophotonics (LAMB), requires one (1) Brand Name Spectra-Physics (Newport Corporation / MKS Instruments) InSight® X3¿ Dual Ultrafast Laser System to integrate with an existing Thorlabs Veneto inverted multiphoton microscope for Fluorescence Lifetime Imaging Microscopy (FLIM) and Stimulated Raman Scattering (SRS) pump-probe experiments studying the effects of chemotherapeutic agents on cellular metabolism.
-Combined Synopsis11/20/2026
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98027Q00064 PCA-NIA-11888. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition. This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a firm fixed-price award to the responsible offeror whose proposal represents the best value to the Government.
-Combined Synopsis12/14/2026

Additional Details

Solicitation Number

75N98026Q00920

Archive Date

Aug 14, 2026

Office Address

BETHESDA, MD, 20817